SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 368 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,191,558 | +592.3% | 27,869 | +491.9% | 0.02% | +166.7% |
| Q1 2020 | $461,000 | -98.8% | 4,708 | -98.4% | 0.01% | -98.2% |
| Q4 2019 | $37,211,000 | +4.0% | 288,367 | -39.3% | 0.49% | -5.2% |
| Q3 2019 | $35,796,000 | -38.3% | 475,254 | +24.4% | 0.52% | -31.0% |
| Q2 2019 | $58,035,000 | +21.0% | 381,935 | -5.1% | 0.75% | +18.1% |
| Q1 2019 | $47,949,000 | +61.4% | 402,292 | +47.7% | 0.63% | +46.8% |
| Q4 2018 | $29,715,000 | -50.9% | 272,290 | -27.3% | 0.43% | -34.8% |
| Q3 2018 | $60,466,000 | +0.9% | 374,382 | -17.4% | 0.66% | +23.5% |
| Q2 2018 | $59,907,000 | +348.5% | 453,224 | +151.4% | 0.54% | +383.8% |
| Q1 2018 | $13,357,000 | -77.2% | 180,281 | -82.9% | 0.11% | -76.1% |
| Q4 2017 | $58,504,000 | +124.9% | 1,051,473 | +83.4% | 0.46% | +139.7% |
| Q3 2017 | $26,011,000 | – | 573,440 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |